Stock LXEO LEXEO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Lexeo Therapeutics, Inc.

Equities

LXEO

US52886X1072

Market Closed - Nasdaq
Other stock markets
 21:00:00 18/06/2024 BST 		5-day change 1st Jan Change
15.64 USD -3.75% Intraday chart for Lexeo Therapeutics, Inc. -14.02% +16.54%
06-13 Baird Initiates Lexeo Therapeutics With Outperform Rating, $28 Price Target MT
06-06 HC Wainwright Initiates Lexeo Therapeutics at Buy With $22 Price Target MT

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Lexeo Therapeutics, Inc. Announces Not to Stand for Reelection of Bernard Davitian as Director
CI
Lexeo Therapeutics Promotes Sandi See Tai to Chief Development Officer, Makes Other Appointments
MT
Lexeo Therapeutics, Inc. Strengthens Clinical Development Leadership with New Executive Appointments
CI
Lexeo Therapeutics Insider Bought Shares Worth $2,499,992, According to a Recent SEC Filing
MT
Lexeo Therapeutics Insider Bought Shares Worth $4,999,995, According to a Recent SEC Filing
MT
Lexeo Therapeutics Insider Bought Shares Worth $4,999,995, According to a Recent SEC Filing
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LXEO Stock
  4. News Lexeo Therapeutics, Inc.
  5. Insiders